Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 May 2024 | Story Lunga Luthuli and Precious Shamase | Photo Supplied
Student Elections Debates 2024
Themba Hlasho, Executive Director: Student Affairs and Prof Prince Ngobeni, Qwaqwa Campus Principal were part of the debate series.

With South Africans going to the polls on 29 May 2024 for the seventh general elections since 1994, the University of the Free State (UFS) successfully hosted its first Institutional Elections Debate Series across its three campuses. The debates, organised by the Institutional Student Governance Office (ISGO), aimed to stimulate political engagement and intellectual discourse among students.

The debates took place on the three campuses and at different levels.  The debates were very successful; students were enthusiastic and well prepared to field critical questions to panellists.  The level of intellectual engagement was high and the facilitator, Ace Moloi – with his fine facilitation skills – helped to take the debates to higher levels.

Motlogelwa Moema, Head of the Student Governance Office, emphasised the alignment of the debates with the UFS’ commitment to societal progress and intellectual enquiry. "As an institution of higher learning, the UFS is committed to producing graduates who can function at various levels of society, contributing meaningfully to societal and intellectual enquiry. Platforms such as the debate series are important in stimulating political as well as electoral involvement while producing students who are leaders," Moema stated.

Student engagement in the electoral process was a key focus of the debates, with discussions highlighting the importance of translating campus political activity into national civic duty. Moema noted, "By bringing representatives from various political parties to all three campuses of the university, we ensured that students not only understood the importance of their votes, but also that they were able to align their values with those of the parties campaigning for their votes."

Informed voters: The debate allowed students to hear directly from the candidates about their platforms and stances on important issues. This can help students make informed decisions when they cast their votes.

Increased engagement: By hosting the debate, the Student Governance Office is encouraging student participation in the national elections. This led to a more vibrant and engaged student body.

Key themes of the debates included student funding, health care, governance, accountability, and economic policy. "The most topical theme across all three campuses was student funding. Additionally, students demonstrated great interest in the National Health Insurance, governance, and economic policies," Moema said, illustrating the depth and breadth of the discussions.

Reflecting on the role of universities in fostering political awareness, Moema acknowledged a generational disengagement from political activism. However, he stressed the importance of universities in cultivating a culture of debate and free thinking. "The recent debate series marked the beginning of the ISGO’s commitment to reviving dialogue across the university," he added.

Moema also highlighted the importance of universities in promoting critical enquiry and fact-checking, particularly during election periods. "Universities have a crucial role in creating platforms for fact-checking, critical enquiry, and clarification," he remarked.

Looking ahead, Moema hopes that the debate series will have a lasting impact on students’ democratic participation. "In the short term, the most ideal impact of the debate series should be a great turnout on election day. In the medium term, we hope to see the same energy during CSRC elections on all three campuses," he said.

The debate series was deemed a success, with significant improvements in turnout and the quality of engagement. "Our students showed a great level of tolerance for divergent views and respect for one another. The audience asked pertinent questions, showing remarkable understanding of societal dynamics, governance, social justice, and leadership values," Moema concluded.

The debates were moderated by Ace Moloi, a former student leader and award-winning journalist, whose experience and understanding of the university’s values greatly contributed to the event’s success.

The UFS is committed to developing well-rounded graduates who can think critically and contribute meaningfully to society. Looking ahead, the UFS hopes to see a high voter turnout on 29 May and continued student involvement in future elections. The debates' focus on critical thinking and informed participation aligns with Vision 130's objective of developing well-rounded graduates who can contribute meaningfully to society.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept